Health
Ponatinib identified as a potent inhibitor of SARS-CoV2-induced cytokine storm – News-Medical.Net
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor…
To date, vaccination efforts have commenced stemming the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Alongside vaccine campaigns, scientists race to find effective drugs to combat the infection.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine…
Continue Reading